A healthy 12-year old athlete from Southern California who died of pneumonia caused by an MRSA infection.
"A disease I had never heard of was killing my child. For two weeks we watched Carlos deteriorate before our eyes, praying for a miracle with every X-ray taken of his lungs."
An active, sports-driven 9-year-old boy survives a terrifying invasive infection and pneumonia caused by MRSA.
"Everything the doctors said to me seemed to be preparing me for the worst. Brock underwent five invasive surgeries, on his shoulder and in his chest..."
A healthy 11-year-old girl from Tuscon, Ariz., who spent months in the hospital fighting several antibiotic-resistant infections and needed a lung transplant to save her life.
"Addie walked into the hospital with me on May 19, 2011, and would not pass again through those doors until October, five months later."
A 19-year-old from the Seattle area battles several NDM-1 positive antibiotic-resistant infections as he recovers from a train accident that cost him his right leg.
"My life consists of watchful waiting and praying that the infection, like some awful type of cancer, does not return."
Because of antibiotic resistance, many bacterial infections have become impossible to treat. New antibiotics are desperately needed to save patients' lives, but few new drugs are in pharmaceutical companies' research and development (R&D) pipelines. Low returns on investments and an unpredictable and often infeasible approval pathway at the U.S. Food and Drug Administration (FDA) have caused many companies to leave the antibiotics market.
IDSA is working to counter this decline through the 10 x '20 Initiative (read our statement). The initiative seeks a global commitment to create an antibiotic R&D enterprise powerful enough to produce 10 new systemic antibiotics by the year 2020. This effort has the potential to save thousands of lives each year. To achieve our goal, IDSA is working with a broad range of stakeholders in the United States and globally. We need your help!
Join other medical societies, public health organizations, and universities in endorsing the 10 x '20 initiative. See who else has joined us >>
To see how antimicrobial resistance is affecting people at the state level, click here >>
If you or a loved one have been devastated by an antibiotic resistant bacterial infection and you would like to share your story, please contact John Heys.
Spread the word
Bugs Without Borders: The Global Challenge of MDROs -
Feb 08, 2013
Fighting Superbugs -
Oct 07, 2012
Resistance to Antibiotics is Becoming a Crisis -
Jul 10, 2012
Kidney-Damage Drug Seen Attacking Spread of Superbacteria -
Jun 10, 2012
1300 Wilson Boulevard | Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2013 Infectious Diseases Society of America